New study checks HIV drug safety in newborns
NCT ID NCT05406583
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study looked at how safe and tolerable the HIV drug dolutegravir is for newborns whose mothers have HIV. Researchers gave the medicine to 48 infants during their first month of life and monitored them for 16 weeks. The goal was to find a safe dose that works well alongside standard HIV prevention. The study took place in Brazil, South Africa, Thailand, and the United States.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine/ Texas Children's Hospital NICHD CRS
Houston, Texas, 77030, United States
-
Bronx-Lebanon Hospital Center NICHD CRS
The Bronx, New York, 10457, United States
-
Chiang Mai University HIV Treatment
Chiang Mai, 50200, Thailand
-
Chiangrai Prachanukroh Hospital NICHD CRS
Chiang Rai, 57000, Thailand
-
David Geffen School of Medicine at UCLA NICHD CRS
Los Angeles, California, 90095-1752, United States
-
Emory University School of Medicine NICHD CRS
Atlanta, Georgia, 30322, United States
-
FAMCRU
Cape Town, 7500, South Africa
-
Rush University, Cook County Hospital Chicago NICHD CRS
Chicago, Illinois, 60612, United States
-
Siriraj Hospital, Mahidol University NICHD CRS
Bangkok, 10700, Thailand
-
Soweto
Johannesburg, Gauteng, 1864, South Africa
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105-3678, United States
-
USC - Maternal Child Adolescent/Adult Center
Los Angeles, California, 90033-1075, United States
-
Umlazi
Durban, KwaZulu-Natal, 4013, South Africa
-
University of Colorado Denver NICHD CRS
Aurora, Colorado, 80045, United States
-
Wits RHI Shandukani Research Centre CRS
Johannesburg, Gauteng, 2001, South Africa
Conditions
Explore the condition pages connected to this study.